| |
|
|
| |
|
The Micro Cap
Newsletter
Pretty in Pink? + OTCBB
Medical Equipment Issue |
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
In This Issue:
|
|
TGTI.PK, PCAI.PK, UTEI.PK |
|
MBSB.OB |
|
Got Microcaps? |
|
|
The Microcap Newsletter is
seen by thousands of unique
small issue investors eager
to see whats emerging on
Wall Street.
If you own a company, or
just know of one that you
would like to see on
Microcaps.com, please let us
know.
|
|
|
|
|
|
Dear Brandon,
In this edition of
The Microcap Newsletter
we would like to introduce 3
new pink sheet issues and 1
OTCBB issue.
|
|
Pretty in Pink?
- TGTI.PK, PCAI.PK & UTEI.PK
take center stage... |
--------------------------------------------------------------------------
TenthGate
International, Inc. -
Pinksheets:
TGTI
TenthGate
International, Inc. ("TenthGate")
is a medical holding company
seeking "life changing"
technologies to acquire and
develop. The current scope of
the company's seven acquired
technologies includes two unique
FDA approved medical devices and
5 unique technology license
venues related to an emerging
melanoma cancer diagnostics and
treatment.
TenthGate International, Inc.
has organized itself into unique
business units as subsidiary
organizations. The purpose of
this structure is to allow
focused application of capital
resources to advance the
development and
commercialization of each
acquired technology.
Tenthgate works with several
leading technology search and
transfer organizations to
include: STC.UMN, Adjuvant,
UTEK Corporation and Core
Concepts, LLC to keep their
technology pipeline full. The
Company will continue to source
strategically qualified partners
to support company operations,
technology acquisitions, product
development, manufacturing,
sales and distribution and
compliance. There is an existing
manufacturing relationship with
Tuthill Plastics Group in
Clearwater, FL and medical
product finishing, sales and
distribution agreement with
DeRoyal Medical in Powell, TN.
Symbol: Pinksheets: TGTI
Outstanding: 5.5 Million
Estimated Float: 3.4
Million
Learn more about the stock:
http://www.tenthgate.biz
http://finance.yahoo.com/q?s=TGTI.PK
--------------------------------------------------------------------------
Petroleum Consolidators of
America - Pinksheets:
PCAI
Petroleum
Consolidators of America aims to
capitalize on the highly
fragmented sector's continued
growth by acquiring,
consolidating and improving
strategically located gasoline
stations and their related
convenience stores. Under the
PCAI umbrella, profitable retail
gasoline and C-store locations
benefit from a number of
economies of scale and operating
efficiencies leveraged by the
company's highly experienced
management team and advisory
board who have developed key
industry relationships.
The company plans to implement a
growth strategy. In fact, retail
distribution, new product
implementation and other
improvements have increased
top-and-bottom-line growth and
helped to reduce overhead and
inventory costs.
As the fall season approaches,
and with initial consolidation
expenses behind them, Petroleum
Consolidators, Inc. expects to
continue to exceed prior
performance at both facilities
by continually streamlining
operations, as well as enhancing
ordering and inventory controls.
Management believes successful
consolidation in this
highly-fragmented marketplace
requires careful considerations
-- including acquisition
structure, profitability
assessment and lengthy due
diligence requirements. As such,
PCAI believes that their
current, targeted acquisition
strategy will continue to
benefit the Company over the
long term.
Symbol: Pinksheets: PCAI
Estimated Float: 1
million
- Over 4 million dollars in
revenue!
- Expansion plans in place!
Learn more about the stock:
http://www.petroleumconsolidators.com
http://finance.yahoo.com/q?s=PCAI.PK
--------------------------------------------------------------------------
UTEC Inc. - Pinksheets:
UTEI
UTEC's
services have been used by the
Department of Defense,
Department of Transportation,
the Bureau of Alcohol Tobacco
and Firearms and other
government agencies. UTEC's
customers also include
multinational automotive air bag
manufacturers, and UTEC has been
a subcontractor on a number of
demilitarization programs.
UTEC Inc. has launched the
Hazardous Waste Destruction
Division and our program to
manufacture the Glid-Arc Plasma
Oxidizer focusing on the
complete destruction of solid
and liquid hazardous chemicals
and biologicals. UTEC Inc. has
signed an agreement with
Ceramatec Inc. and obtained the
exclusive license to manufacture
Ceramatec's Glid-Arc Plasma
Oxidizer for the total and
complete destruction of solid
and liquid hazardous chemicals
and Biologicals. The Waste
Destruction Division will
provide solutions for the
low-volume high-margin
processing of highly reactive,
toxic and hazardous waste. The
waste destruction system will
add a third leg to UTEC's
current business strategy,
complementing the energetic
materials and chemical
distribution businesses,
expanding and strengthening the
company's business. This Bio
waste Oxidizer has multiple
applications for Medical waste
and the company plans a full
scale program aimed at Medical
waste management companies.
Symbol: Pinksheets: UTEI
Outstanding: 50 Million
Estimated Float: 2.9
Million (Tightly held)
Learn more about the stock:
http://www.utec-corp.com
http://finance.yahoo.com/q?s=UTEI.PK
|
|
OTCBB Medical Equipment Issue -
MBSB.OB |
--------------------------------------------------------------------------
Wound Care Innovations, LLC -
OTCBB: MBSB
Wound
Care Innovations, LLC,
distributes collagen-based FDA
cleared wound care products to
healthcare providers, such as
physicians, clinics, and long
term care facilities in the
United States. It holds certain
exclusive and nonexclusive
distribution rights to
CellerateRx® products.
CellerateRx® provides
unprecedented, range of use,
cost savings and patient
friendliness. Wound Care
Innovations, LLC (WCI) was
formed with the sole purpose of
introducing and distributing a
truly unique and innovative
solution to the greater than
$2.5 billion domestic US wound
care market - CellerateRX ®.
WCI is the exclusive distributor
of a line of Activated Collagen
wound care products featuring a
patented molecular form of
collagen called CellerateRX®.
The Company's immediate market
is with primary buyers including
healthcare providers
(physicians, clinics, hospitals,
homecare, long term care and DME),
and a vast secondary consumer
market. WCI's line of Activated
Collagen-based products are all
FDA cleared as medical devices
and have been cleared for use in
the management of chronic &
acute wounds and skin ulcers.
Symbol: OTCBB: MBSB
Outstanding: 16.1 Million
Public Float: 1 Million
(Tightly Held)
Learn more about the stock:
http://www.celleraterx.com
http://finance.yahoo.com/q?s=MBSB.OB
|
|
|
We hope you've found our
publication both interesting
and informative. If you have
any questions or comments
about this newsletter, or
the companies herein, please
contact us and we would be
happy to speak with you
Sincerely,
The Microcaps.com Team
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
| |
|
DISCLAIMER & SAFE HARBOR
PROVISIONS:
Microcaps.com has been
compensated $5000 cash for
the dissemination of this
email and other creative
and/or web development
services for TGTI.PK,
PCAI.PK, UTEI.PK & MBSB.OB.
Certain oral statements made
by management and certain
statements contained in
press releases and periodic
reports issued by these
companies (the "Company"),
as well as those contained
herein, that are not
historical facts are
considered "forward-looking
statements" within the
meaning of Section 21E of
the Securities and Exchange
Act of 1934 and, because
such statements involve
risks and uncertainties,
actual results may differ
materially from those
expressed or implied by such
forward-looking statements.
Forward-looking statements,
including those in
Management's Discussion and
Analysis, are statements
regarding the intent, belief
or current expectations,
estimates or projections of
the Company, its Directors
or its Officers about the
Company and the industry in
which it operates, and are
based on assumptions made by
management. Forward looking
statements include without
limitation statements
regarding: (a) the Company's
strategies regarding growth
and business expansion,
including future
acquisitions; (b) the
Company's financing plans;
(c) trends affecting the
Company's financial
condition or results of
operations; (d) the
Company's ability to
continue to control costs
and to meet its liquidity
and other financing needs;
(e) the declaration and
payment of dividends; and
(f) the Company's ability to
respond to changes in
customer demand and
regulations. Although the
Company believes that its
expectations are based on
reasonable assumptions, it
can give no assurance that
the anticipated results will
occur. When issued in this
report, the words "expects,"
"anticipates," "intends,"
"plans," "believes,"
"seeks," "estimates," and
similar expressions are
generally intended to
identify forward-looking
statements.
Important factors that could
cause the actual results to
differ materially from those
in the forward-looking
statements include, among
other items, (i) changes in
the regulatory and general
economic environment; (ii)
conditions in the capital
markets, including the
interest rate environment
and the availability of
capital; (iii) changes in
the competitive marketplace
that could affect the
Company's revenue and/or
cost and expenses, such as
increased competition, lack
of qualified marketing,
management or other
personnel, and increased
labor and inventory costs;
(iv) changes in technology
or customer requirements,
which could render the
Company's technologies
noncompetitive or obsolete;
(v) new product
introductions, product sales
mix and the geographic mix
of sales.
The Company disclaims any
intention or obligation to
update or revise
forward-looking statements,
whether as a result of new
information, future events
or otherwise. Safe Harbor
Statement under the Private
Securities Litigation Reform
Act of 1995: The statements
which are not historical
facts contained in this
advertisement are
forward-looking statements
that involve certain risks
and uncertainties including
but not limited to risks
associated with the
uncertainty of future
financial results,
additional financing
requirements, development of
new products, governmental
approval processes, the
impact of competitive
products or pricing,
technological changes, and
the effect of economic
conditions.
|
|
|
|
| |
|
|
|
|